PreveCeutical Medical Inc.
PRVCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13 | $19 | $12 | $14 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $5 | $5 | $4 |
| Enterprise Value | $17 | $24 | $17 | $19 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$1 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.002 | -0.001 | -0 |
| % Growth | 54.5% | -57.1% | -250% | – |
| Operating Cash Flow | -$0 | -$1 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$1 | -$0 | -$0 |